Rhinomed Ltd banner

Rhinomed Ltd
ASX:RNO

Watchlist Manager
Rhinomed Ltd Logo
Rhinomed Ltd
ASX:RNO
Watchlist
Price: 0.04 AUD
Market Cap: AU$11.3m

Rhinomed Ltd
Investor Relations

Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. The company is headquartered in Richmond, Victoria. The company went IPO on 2007-09-21. The Company’s products include Mute, Turbine, Pronto Sleep, and Pronto Clear. The Mute is a nasal technology that is designed to allow the user to manage the sleep by breathing more and snoring less. The Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Pronto Sleep, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the soothing vapors of four pure essential oils. Pronto Clear, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the ability to deliver the vapors of six pure essential oils traditionally known to clear a stuffy nose naturally. Its products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics, and sports stores.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Michael Johnson
CEO, MD & Executive Director
No Bio Available
Mr. Sean Slattery
CFO & Company Secretary
No Bio Available

Contacts

Address
VICTORIA
RICHMOND
Cremorne, 97 Green Street
Contacts
+61384160900.0
www.rhinomed.com.au